These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34316503)

  • 1. Cohabitation With a Known Coronavirus Disease 2019 Case Is Associated With Greater Antibody Concentration and Symptom Severity in a Community-Based Sample of Seropositive Adults.
    Schrock JM; Ryan DT; Saber R; Benbow N; Vaught LA; Reiser N; Velez MP; Hsieh R; Newcomb M; Demonbreun AR; Mustanski B; McNally EM; D'Aquila R; McDade TW
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab244. PubMed ID: 34316503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to SARS-CoV-2 within the household is associated with greater symptom severity and stronger antibody responses in a community-based sample of seropositive adults.
    Schrock JM; Ryan DT; Saber R; Benbow N; Vaught LA; Reiser N; Velez MP; Hsieh R; Newcomb M; Demonbreun AR; Mustanski B; McNally EM; D'Aquila R; McDade TW
    medRxiv; 2021 Mar; ():. PubMed ID: 33758903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
    Abela IA; Schwarzmüller M; Ulyte A; Radtke T; Haile SR; Ammann P; Raineri A; Rueegg S; Epp S; Berger C; Böni J; Manrique A; Audigé A; Huber M; Schreiber PW; Scheier T; Fehr J; Weber J; Rusert P; Günthard HF; Kouyos RD; Puhan MA; Kriemler S; Trkola A; Pasin C
    mBio; 2024 Feb; 15(2):e0272223. PubMed ID: 38270455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urticaria after breakthrough Omicron BA.5.1 severe acute respiratory syndrome coronavirus 2 infection in a triple-vaccinated (Pfizer) patient: a case report.
    Ciuoderis K; Perez L; Alvarez C; Usuga J; Carvajal L; Cardona A; Maya MA; Cloherty G; Hernandez-Ortiz JP; Osorio JE
    J Med Case Rep; 2023 May; 17(1):177. PubMed ID: 37138300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Puenpa J; Wanlapakorn N; Chirathaworn C; Sudhinaraset N; Sripramote M; Chalongviriyalert P; Jirajariyavej S; Kiatpanabhikul P; Saiyarin J; Soudon C; Thienfaidee O; Ayuthaya TPN; Brukesawan C; Intharasongkroh D; Chaiwanichsiri D; Issarasongkhram M; Kitphati R; Mungaomklang A; Thitithanyanont A; Nagavajara P; Poovorawan Y
    PLoS One; 2022; 17(4):e0267102. PubMed ID: 35446889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients.
    Fraser DD; Cepinskas G; Slessarev M; Martin CM; Daley M; Patel MA; Miller MR; Patterson EK; O'Gorman DB; Gill SE; Oehler S; Miholits M; Webb B
    Crit Care Explor; 2021 Mar; 3(3):e0369. PubMed ID: 33786445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Levels of Neutralizing Antibodies After Natural Infection With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community-Based Serological Study.
    McDade TW; Sancilio A; D'Aquila R; Mustanski B; Vaught LA; Reiser NL; Velez ME; Hsieh RR; Ryan DT; Saber R; McNally EM; Demonbreun AR
    Open Forum Infect Dis; 2022 Mar; 9(3):ofac055. PubMed ID: 35252468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates.
    Kubiak JM; Murphy EA; Yee J; Cagino KA; Friedlander RL; Glynn SM; Matthews KC; Jurkiewicz M; Sukhu AC; Zhao Z; Prabhu M; Riley LE; Yang YJ
    Am J Obstet Gynecol; 2021 Jul; 225(1):73.e1-73.e7. PubMed ID: 33497654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-stratified seroprevalence of severe acute respiratory syndrome coronavirus among children in Hong Kong.
    Lee PP; Wong WH; Leung GM; Chiu SS; Chan KH; Peiris JS; Lam TH; Lau YL
    Pediatrics; 2006 Jun; 117(6):e1156-62. PubMed ID: 16682490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
    Cavanagh D
    Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
    Upasani V; Townsend K; Wu MY; Carr EJ; Hobbs A; Dowgier G; Ragno M; Herman LS; Sharma S; Shah D; Lee SFK; Chauhan N; Glanville JM; Neave L; Hanson S; Ravichandran S; Tynan A; O'Sullivan M; Moreira F; Workman S; Symes A; Burns SO; Tadros S; Hart JCL; Beale RCL; Gandhi S; Wall EC; McCoy L; Lowe DM
    Clin Infect Dis; 2023 Oct; 77(7):950-960. PubMed ID: 37338118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.
    Togashi K; Hatakeyama S; Yoneyama T; Hamaya T; Narita T; Fujita N; Iwamura H; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Ohyama C
    Int J Urol; 2022 Jul; 29(7):733-739. PubMed ID: 35362143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity.
    Graham NR; Whitaker AN; Strother CA; Miles AK; Grier D; McElvany BD; Bruce EA; Poynter ME; Pierce KK; Kirkpatrick BD; Stapleton RD; An G; van den Broek-Altenburg E; Botten JW; Crothers JW; Diehl SA
    Clin Transl Immunology; 2020; 9(10):e1189. PubMed ID: 33072323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.
    Servian CDP; Spadafora-Ferreira M; Dos Anjos DCC; Guilarde AO; Gomes-Junior AR; Borges MASB; Masson LC; Silva JMM; de Lima MHA; Moraes BGN; Souza SM; Xavier LE; de Oliveira DCA; Batalha-Carvalho JV; Moro AM; Bocca AL; Pfrimer IAH; Costa NL; Feres VCR; Fiaccadori FS; Souza M; Gardinassi LG; Durigon EL; Romão PRT; Jorge SAC; Coelho V; Botosso VF; Fonseca SG
    Front Immunol; 2023; 14():1206979. PubMed ID: 37876932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive serologic profile and specificity of maternal and neonatal cord blood SARS-CoV-2 antibodies.
    Boelig RC; Chaudhury S; Aghai ZH; Oliver EA; Mancuso F; Berghella V; Bergmann-Leitner ES
    AJOG Glob Rep; 2022 Feb; 2(1):100046. PubMed ID: 34961853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2.
    Grandjean L; Saso A; Torres Ortiz A; Lam T; Hatcher J; Thistlethwayte R; Harris M; Best T; Johnson M; Wagstaffe H; Ralph E; Mai A; Colijn C; Breuer J; Buckland M; Gilmour K; Goldblatt D;
    Clin Infect Dis; 2022 Apr; 74(7):1220-1229. PubMed ID: 34218284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of antibody titers to SARS-CoV-2 vaccination and clinical outcomes during the predominance of the Omicron variant in Colombia.
    Montero C; Torres R; Reina M; Flechas J; Andrade D; Moreno S; Granados C; Yomayusa N
    SAGE Open Med; 2023; 11():20503121231187754. PubMed ID: 37489136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Bolton MJ; Arevalo CP; Anderson EM; Goodwin EC; Hensley SE; Puopolo KM
    JAMA Pediatr; 2021 Jun; 175(6):594-600. PubMed ID: 33512440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity.
    Wang J; Li D; Cameron A; Zhou Q; Wiltse A; Nayak J; Pecora ND; Zand MS
    J Infect Dis; 2022 Aug; 226(3):474-484. PubMed ID: 35091739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.